Benefits include remission and control of hypertension while cutting dependence on antihypertensive medications<\/p>\n<\/h3>\n
By Lori Solomon HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Sept. 10, 2024 (HealthDay News) — Bariatric surgery emerges as a durable solution for obesity-related hypertension, according to a study presented at the American Heart Association Hypertension Scientific Sessions 2024, held from Sept. 5 to 8 in Chicago.<\/p>\n
Sneha Annie Sebastian, M.D., from Azeezia Medical College in Kerala, India, and a residency candidate from Alberta, Canada, and colleagues synthesized findings from 18 pivotal randomized controlled trials (1,386 patients with obesity) to evaluate the long-term effects of bariatric surgery on hypertension in individuals with obesity compared to medical or lifestyle management.\u00a0<\/p>\n
The researchers found that in a pooled analysis, there was a statistically significant difference in the rate of hypertension remission between patients who underwent bariatric surgery versus patients on medical or lifestyle management (risk ratio [RR], 2.77; 95 percent confidence interval [CI], 1.26 to 6.10). Relatedly, there was a substantial reduction in the use of antihypertensive medications while maintaining controlled blood pressure (RR, 7.10; 95 percent CI, 4.38 to 11.51), with no heterogeneity among findings. There were also significant improvements in systolic blood pressure control associated with bariatric surgery.<\/p>\n
“Bariatric surgery is an effective solution for managing obesity-related hypertension,” Sebastian said in a statement. “Future research should focus on conducting randomized controlled trials with long-term follow-up and large sample sizes, with a specific emphasis on hypertension outcomes, as many currently focus on diabetes outcomes.”<\/p>\n
Press Release<\/a><\/p>\n